Pursuing Later Treatment Options (PLATO II)
The PLATO II project is a study of triple class virologic failure (TCVF): failure of the three original antiretroviral drug classes. Using data from both adult and paediatric cohorts in the COHERE collaboration, the objectives of PLATO II are to study: i) incidence and predictors of TCVF; ii) outcomes in people with TCVF; iii) and antiretroviral resistance in people with TCVF.
Click here to go back to the list of studies in the HIV Epidemiology and Biostatistics Group.
Page last modified on 17 apr 13 15:31